Stocks Health care ELAB
NASDAQ · Health carePMGC Holdings Inc. (ELAB)
It posted a net loss of $13.5M. In fiscal 2025 capital spending exceeded operating cash flow by $6.4M. At June 30, 2026 it held $18.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about PMGC Holdings Inc.
- Net worth
- PMGC Holdings Inc. has a market value (market cap) of $12.8M at the latest share price, and shareholders' equity of $16.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $590.1K (-65.5% year on year), with a net loss of $7.7M.
- Cash flow
- In fiscal 2025 operations used $5.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- PMGC Holdings Inc.'s next report was expected around October 22, 2026 and is not on file with the SEC yet.
What PMGC Holdings Inc. does
PMGC Holdings Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ELAB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $590.1K | -$7.7M | n/a | -$6.4M |
| 2024 | n/a | -$6.2M | n/a | -$5.5M |
| 2023 | $1.7M | -$4.3M | -$0.40 | -$4.6M |
| 2023 | $766.3K | -$1.8M | -$0.19 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ELAB ranks in Health care
Latest SEC filings
What PMGC Holdings Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 29, 2026Activist stake (5% or more) SCHEDULE 13D
- September 18, 2026
- September 2, 2026
- August 27, 2026
- August 14, 2026
- July 9, 2026
- July 7, 2026
- July 1, 2026
- June 8, 2026
- June 5, 2026
Insider trades
What the people running PMGC Holdings Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns ELAB
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Streeterville Capital LLC13G, passive with 2 related filers | 9.9% | May 27, 2026 |
| Braeden Lichti13D, may seek influence with 1 related filers | 7.4% | June 3, 2026 |
| Graydon Bensler13D, may seek influence with 1 related filers | 7.4% | June 3, 2026 |
Largest institutional holders
Insiders
Questions about ELAB
What does PMGC Holdings Inc. do?
PMGC Holdings Inc. is a company in the Health care sector, listed on NASDAQ as ELAB. Its shares trade on NASDAQ under the ticker ELAB.
What is PMGC Holdings Inc.'s net worth?
PMGC Holdings Inc. has a market value (market cap) of $12.8M at the latest share price, and shareholders' equity of $16.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is PMGC Holdings Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $13.5M.
When did PMGC Holdings Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake (5% or more) from September 29, 2026.
When is PMGC Holdings Inc.'s next earnings report?
PMGC Holdings Inc.'s next report was expected around October 22, 2026 and is not on file with the SEC yet.
Similar companies
Compare ELAB with
Follow ELAB
Get an email when PMGC Holdings Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values PMGC Holdings Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.